- Wanhua Chemical recorded a net income of 4.16 billion yuan in the 1st quarter of 2024.
- The company’s revenue for the same period stood at 46.16 billion yuan.
- There was an increase of +2.57% in net income compared to the previous period.
- Market sentiment about Wanhua Chemical is overwhelmingly positive with 34 buys, no holds, and no sells.
A look at Wanhua Chemical Group Co A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Wanhua Chemical Group Co A, a company specializing in the development, manufacturing, and marketing of various chemical products, has received a mixed review in its Smartkarma Smart Scores. With a solid Dividend score of 4 and Growth score of 4, the company shows promise in terms of its ability to generate returns for shareholders and its potential for expansion. However, its Value and Resilience scores are lower at 2, indicating some room for improvement in terms of its value proposition and stability. On the positive side, Wanhua Chemical Group Co A has scored a high 5 in Momentum, suggesting strong market momentum and potential for future growth.
In summary, Wanhua Chemical Group Co A‘s overall outlook as indicated by the Smartkarma Smart Scores is a mixed bag. While it demonstrates strength in terms of dividend, growth potential, and market momentum, there are areas such as value and resilience where the company could focus on improvement. Investors may want to closely monitor how Wanhua Chemical Group Co A addresses these aspects to assess its long-term sustainability and growth prospects in the chemical industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
